Moderna, Inc. 8-K

What Happened
Moderna, Inc. announced its financial results for the quarter ended December 31, 2025 via a press release dated February 13, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8-K filed on February 13, 2026; the filing was signed by Chief Financial Officer James M. Mock.

Key Details

• Press release announcing Q4 2025 results dated February 13, 2026 (Exhibit 99.1).
• Quarter covered: three months ended December 31, 2025.
• The Form 8-K expressly states the information is furnished (not “filed”) and therefore not subject to Section 18 liability or automatically incorporated by reference in other filings.
• Interactive XBRL cover page data included as Exhibit 104; filing signed by CFO James M. Mock.

Why It Matters
Quarterly results are a primary source of updated earnings, revenue, and financial-condition information that investors use to assess Moderna’s near-term performance. The 8-K alerts investors that the company has publicly released its Q4 2025 figures (see the press release for the detailed numbers and any commentary). Note the company treated the release as furnished rather than filed, which affects legal liability and incorporation into other SEC filings.